Adrian van den Hoven

Adrian van den Hoven joined Medicines for Europe as a director-general in September 2013. His priorities at
Medicines for Europe are to stimulate competition in off-patent medicine markets, to foster market access
for generic, biosimilar and value added medicines, to support policy measures for sustainable pricing, to
promote high regulatory standards while ensuring that the associated costs can be integrated into market
dynamics and to develop a coherent EU industrial strategy to support the
long-term viability of the generic, biosimilar and value added medicines industries.

Adrian is also the president of the European Medicines Verification Organisation (EMVO) for the implementation of serialisation
against falsified medicines.
Prior to joining Medicines for Europe, Adrian van den Hoven was deputy-director general of BUSINESSEUROPE where he was
responsible for the international relations department, covering trade negotiations and bilateral relations, and the industry department, covering industrial, energy, environmental and research policy. He previously worked as an international relations researcher and an adjunct professor in Italy (EUI), France (Nice) and Canada (Windsor).

He obtained his doctorate in Political Science from the University of Nice, France in 2000.